Table 1

Multivariate analysis for RFS and OS

CovariatesRFSOS
Before IPTW-adjustmentAfter IPTW-adjustmentBefore IPTW-adjustmentAfter IPTW-adjustment
HR (95% CI)P valueHR (95% CI)P valueHR (95% CI)P valueHR (95% CI)P value
Solitary
 LR versus LT3.79 (1.93 to 7.46)<0.0013.66 (1.80 to 7.44)<0.0012.33 (1.10 to 4.91)0.0271.62 (0.74 to 3.55)0.226
 LA versus LT9.56 (5.11 to 17.89)<0.00110.28 (5.22 to 20.23)<0.0016.42 (3.34 to 12.31)<0.0016.07 (3.13 to 11.75)<0.001
 LA versus LR2.52 (1.60 to 3.98)<0.0012.81 (1.75 to 4.50)<0.0012.76 (1.55 to 4.92)<0.0013.74 (2.00 to 7.02)<0.001
Multiple
 LR versus LT7.94 (3.19 to 19.75)<0.00112.40 (4.60 to 33.44)<0.0015.56 (2.31 to 13.36)<0.0014.04 (1.78 to 9.16)<0.001
 LA versus LT6.04 (2.36 to 15.44)<0.0017.14 (2.47 to 20.67)<0.0012.38 (0.92 to 6.18)0.0751.79 (0.71 to 4.52)0.219
 LA versus LR0.76 (0.40 to 1.46)0.4090.58 (0.29 to 1.14)0.1150.43 (0.20 to 0.90)0.0250.44 (0.20 to 0.98)0.043
Operation
 LT: multiple versus solitary1.27 (0.46 to 3.49)0.6490.75 (0.25 to 2.25)0.6051.43 (0.56 to 3.66)0.4611.56 (0.65 to 3.79)0.322
 LR: multiple versus solitary2.65 (1.48 to 4.74)0.0012.53 (1.46 to 4.38)<0.0013.40 (1.77 to 6.56)<0.0013.90 (1.94 to 7.84)<0.001
 LA: multiple versus solitary0.80 (0.44 to 1.45)0.4580.52 (0.28 to 0.96)0.0350.53 (0.27 to 1.04)0.0650.46 (0.22 to 0.96)0.038
Gender (male)1.99 (1.14 to 3.47)0.0162.65 (1.40 to 5.03)0.003
Aetiology
 HCV versus HBV0.57 (0.26 to 1.26)0.1640.65 (0.28 to 1.52)0.3180.81 (0.34 to 1.95)0.6430.93 (0.38 to 2.27)0.880
 Others versus HBV1.72 (1.05 to 2.80)0.0311.80 (1.06 to 3.06)0.0292.47 (1.43 to 4.27)0.0012.21 (1.21 to 4.04)0.010
 Others versus HCV3.03 (1.25 to 7.35)0.0142.78 (1.07 to 7.21)0.0353.03 (1.15 to 8.02)0.0252.37 (0.86 to 6.48)0.094
In(AFP) (ng/mL)1.09 (1.00 to 1.18)0.0391.08 (0.99 to 1.18)0.078
ALBI score1.35 (1.03 to 1.76)0.0311.37 (1.04 to 1.82)0.0271.51 (1.12 to 2.02)0.0061.35 (1.00 to 1.83)0.051
Tumour size (cm) (3–5 vs ≤3)1.43 (0.97 to 2.11)0.075
  • Variables that achieved significance at the 0.1 level in the univariate Cox proportional hazards (PH) model were included in the multivariate analysis. Statistical analyses were performed using R V.3.5.2, and p<0.05 was considered statistically significant.

  • AFP, α-fetoprotein; ALBI, albumin-bilirubin; OS, overall survival; PH, proportional hazards; RFS, recurrence-free survival.